Company Filing History:
12 out of 321 
5 out of 22 
4 out of 10 
Years Active: 2012-2021
Title: Innovator Sei-Ryang Oh: Pioneering Solutions for Asthma and Blood Cancer
Introduction: Sei-Ryang Oh, an accomplished inventor based in Daejeon, South Korea, has made significant contributions to the fields of biotechnology and pharmaceuticals. With a remarkable portfolio of 14 patents, his work focuses on innovative solutions for treating serious health conditions such as asthma and blood cancer.
Latest Patents: Oh's latest patents include a pharmaceutical composition containing a monoacetyldiacylglycerol compound aimed at preventing or treating asthma. This innovative formulation demonstrates the ability to inhibit IL-4 expression in mouse T cell lymphoma cells and has shown promise in reducing airway hypersensitivity and inflammatory cell infiltration. The composition offers a potential alternative to current asthma therapies, exhibiting no toxicity while providing superior therapeutic effects.
Additionally, Oh has developed a composition containing a monoacetyldiglyceride compound for inhibiting blood cancer or metastasis. This compound has exhibited excellent similarities in inhibiting IL-4 expression and the activity of STAT-6, addressing the side effects associated with existing treatments for blood cancer. Like his asthma treatment, this formulation is non-toxic and presents promising therapeutic effects for patients.
Career Highlights: Sei-Ryang Oh has been associated with notable organizations, including the Korea Research Institute of Bioscience and Biotechnology and Enzychem Lifesciences Corporation. His tenure in these institutions has allowed him to further his research and refine his inventiveness in the domain of biotechnology.
Collaborations: Throughout his career, Oh has collaborated with esteemed colleagues such as Kyung Seop Ahn and Ok-Kyoung Kwon. Their cooperative efforts have significantly advanced the research and development of innovative solutions in their respective fields, leading to noteworthy advancements in medical science.
Conclusion: As an inventor, Sei-Ryang Oh continues to pave the way for groundbreaking advancements in the treatment of asthma and blood cancer. His innovative contributions, underscored by his extensive patent portfolio, signify a promising future for therapeutic approaches in biotechnology. Through his work, Oh is not only enhancing medical science but also improving countless lives with his pioneering solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.